Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes

AIDS Research and Human Retroviruses

Volumn 25, Issue 7, 2009, Pages 691-699

  Gandhi, Nimisha ^a   Saiyed, Zainulabedin ^a   Thangavel, Samikkannu ^a   Rodriguez, Jose ^b   Rao, K V K ^a   Nair, Madhavan P N ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b Universidad Central del Caribe School of Medicine   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLADISTICS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 CLADE B; HUMAN IMMUNODEFICIENCY VIRUS 1 CLADE C; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 70349221406     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0299     Document Type: Article

References (35)

1. Essex M: The human immunodeficiency virus (HIV) as a newly evolving pathogen. Southeast Asian J Trop Med Public Health 1997;28(2):127-130.
2. Janssens W, Buve A, and Nkengasong JN: The puzzle of HIV-1 subtypes in Africa. AIDS 1997;11(6):705-712.
3. Rodenburg CM, Li Y, Trask SA, Chen Y, Decker, J, et al.: Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses 2001;17(2):161-168.
4. Geretti AM: HIV-1 subtypes: Epidemiology and significance for HIV management. Curr Opin Infect Dis 2006;19:1-7.
5. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, et al.: The HNRC 500--neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1995;1(3): 231-251.
6. White DA, Heaton RK, and Monsch AU: Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. J Int Neuropsychol Soc 1995;1(3):304-315.
7. Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, and Nanivadekar A: Neurological manifestations of HIV disease. J Assoc Physicians India 2001;49:343-348.
8. Rao VR, Sas AR, Eugenin EA, Siddappa NB, Nelson HB, Berman JW, Ranga U, Tyor WR, and Prasad VR: HIV-1 clade specific differences in the induction of neuropathogenesis. J Neurosci 2008;28(40):10010-10016.
9. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, et al.: Profile of neurologic disorders associated with HIV=AIDS from Bangalore, south India (1989-1996). Indian J Med Res 2000;111:14-23.
10. Riedel D, Ghate M, Nen M, Paranjape R, Mehendale S, Bollinger R, Sacktor N, McArthur J, and Nath A: Screening of human immunodeficiency virus (HIV) dementia in HIV clade C-infected population in India. J Neurovirol 2006; 12:34-38.
11. Gupta SK, Mather KJ, Agarwal R, Saha CK, Considine RV, and Dube MP: Proteinuria and endothelial dysfunction in stable HIV-infected patients: A pilot study. J Acquir Immune Defic Syndr 2007;45(5):596-598.
12. Kedzierska K, Crowe SM, Turville S, and Cunningham AL: The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev Med Virol 2003;13:39-56.
13. Herbein G and Gordon S: 55-and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages. J Virol 1997;71:4150-4156. (Pubitemid 27172437)
14. Nair MP, Pottathil R, Heimer EP, and Schwartz SA: Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: Effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci USA 1988;85(17):6498-6502.
15. Chen M, Singh MK, Balachandran R, and Gupta P: Isolation and characterization of two divergent infectious molecular clones of HIV type 1 longitudinally obtained from a seropositive patient by a progressive amplification procedure. AIDS Res Hum Retroviruses 1997;13(9):743-750.
16. Mayne M, Bratanich AC, Chen P, Rana F, Nath A, and Power C: HIV-1 tat molecular diversity and induction of TNF-alpha: Implications for HIV-induced neurological disease. Neuroimmunomodulation 1998;5(3-4):184-192.
17. Bolognesi DP: Perspectives on the development of anti-HIV vaccines. Curr Opin Biotechnol 1991;2(6):893-896.
18. Robinson WE, Gorny MK, Xu JY, Mitchell WM, and Zolla-Pazner S: Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol 1991;65(8):4169-4176.
19. Tyring SK, Cauda R, Tumbarello M, Ortona L, Kennedy RC, Chanh TC, and Kanda P: Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2. Viral Immunol 1991; 4(1):33-42.
20. Nath A, Conant K, Chen P, Scott C, and Major EO: Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 1999;274:17098-17102.
21. Huang L, Bosch I, Hofmann W, Sodroski J, and Pardee AB: Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol 1998;72:8952-8960.
22. Nair MPN, Saiyed ZM, Nair N, Gandhi N, Rodriguez JW, Boukli N, Vasquez E, Malow RM, and Burbano MJM: Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol 2009; 4(1):129-139.
23. Shively L, Chang L, LeBon JM, Liu Q, Riggs AD, and Singer-Sam J: Real-time PCR assay for quantitative mismatch detection. Biotechniques 2003;34:498-502.
24. Mahajan S, Schwartz S, and Nair MP: Immunological assays for chemokine detection in in vitro culture of CNS cells. Biol Proced Online 2003;5:90-102.
25. Persidsky Y and Gendelman HE: Mononuclear phagocyte immunity and the europathogenesis of HIV-1 infection. J Leukoc Biol 2003;74:691-701.
26. Gendelman HE: Neural immunity: Friend or foe? J. Neurovirol. 2002; 8:474-479.
27. Campbell GR, Watkins JD, Singh KK, Loret EP, and Spector SA: Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol 2007;81(11):5919-5928.
28. Li JB, Lee DC, Cheung KW, and Lau AS: Mechanisms of HIV Tat upregulation of IL-10 and other cytokine expression: Kinase signaling and PKR-mediated immune response. FEBS Lett 2005;579:3055-3062.
29. Siddappa NB, Venkatramanan M, Venkatesh P, Janki MV, Jayasuryan N, Desai A, Ravi V, and Ranga U: Transactivation and signaling functions of Tat are not correlated: Biological and immunological characterization of HIV-1 subtype C Tat protein. Retrovirology 2006;3:53.
30. Wesselingh SL, Tyor WR, and Griffin DE: Cytokines and HIV associated dementia. In: Cytokines and CNS (Ransohoff RM and Benveniste EN, eds.). CRC Press, Boca Raton, FL, 1996, pp. 287-303.
31. Bukrinsky MI, Nottet HS, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, and Gendelman HE: Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J Exp Med 1995;181:735-745.
32. Breen EC: Pro-and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol Ther 2002;95:295-304.
33. Kumar A, Angel JB, Daftarian MP, Parato K, Cameron WD, Filion L, and Diaz-Mitoma F: Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: Association of IL-10 production with CD28-mediated immune responsiveness. Clin Exp Immunol 1998;114: 78-86.
34. Lin HH, Gaschen BK, Collie M, El-Fishaway M, Chen Z, Korber BT, Beatrice ST, and Zhang L: Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City. J Acquir Immune Defic Syndr 2006;41(4):399-404.
35. Tovanabutra S, Brodine SK, Mascola JR, Sankale JL, Sanders-Buell E, Kim B, Birx DL, and McCutchan FE: Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel. AIDS Res Hum Retroviruses 2005;21(5):424-429.